Healthcare Partners Vii, L.p. - Net Worth and Insider Trading

Healthcare Partners Vii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Healthcare Partners Vii, L.p. owns 4 companies in total, including GlobeImmune Inc (GBIM) , TetraLogic Pharmaceuticals Corp (TLOG) , and Radius Health Inc (RDUS) among others .

Click here to see the complete history of Healthcare Partners Vii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Healthcare Partners Vii, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
GBIM	GlobeImmune Inc	2016-02-17	other: Former 10% Owner
TLOG	TetraLogic Pharmaceuticals Corp	2013-12-17	10 percent owner
RDUS	Radius Health Inc	2011-05-17	10 percent owner
		2009-07-28	10 percent owner

Healthcare Partners Vii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Healthcare Partners Vii, L.p. Ownership Network

Ownership Network List of Healthcare Partners Vii, L.p.

No Data

Ownership Network Relation of Healthcare Partners Vii, L.p.

Healthcare Partners Vii, L.p. Owned Company Details

What does GlobeImmune Inc do?

Who are the key executives at GlobeImmune Inc?

Healthcare Partners Vii, L.p. is the other: Former 10% Owner of GlobeImmune Inc. Other key executives at GlobeImmune Inc include other: Former 10% Owner Healthcare Ventures Vii Lp , other: Former 10% Owner John W Littlechild , and other: Former 10% Owner James H Cavanaugh .

GlobeImmune Inc (GBIM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GlobeImmune Inc (GBIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GlobeImmune Inc (GBIM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GlobeImmune Inc (GBIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

GlobeImmune Inc Insider Transactions

No Available Data

What does TetraLogic Pharmaceuticals Corp do?

Who are the key executives at TetraLogic Pharmaceuticals Corp?

Healthcare Partners Vii, L.p. is the 10 percent owner of TetraLogic Pharmaceuticals Corp. Other key executives at TetraLogic Pharmaceuticals Corp include other: See Remarks Hudson Bay Capital Management Lp , other: See Remarks Lazard Asset Management Llc , and other: See Remarks Nomura Holdings Inc .

TetraLogic Pharmaceuticals Corp (TLOG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TetraLogic Pharmaceuticals Corp (TLOG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TetraLogic Pharmaceuticals Corp (TLOG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TetraLogic Pharmaceuticals Corp (TLOG)'s detailed insider trading history can be found in Insider Trading Tracker table.

TetraLogic Pharmaceuticals Corp Insider Transactions

No Available Data

What does Radius Health Inc do?

Who are the key executives at Radius Health Inc?

Healthcare Partners Vii, L.p. is the 10 percent owner of Radius Health Inc. Other key executives at Radius Health Inc include director & CEO and President G. Kelly Martin , Senior Vice President Elizabeth Messersmith , and Vice President & Sales Danielle Holtschlag .

Radius Health Inc (RDUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Radius Health Inc (RDUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Radius Health Inc (RDUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Radius Health Inc (RDUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Radius Health Inc Insider Transactions

No Available Data

What does Altimmune Inc do?

Who are the key executives at Altimmune Inc?

Healthcare Partners Vii, L.p. is the 10 percent owner of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .

Altimmune Inc (ALT) Insider Trades Summary

Over the past 18 months, Healthcare Partners Vii, L.p. made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net purchase of 9,300 shares made by David Drutz , a net sale of 20,000 shares made by Wayne Pisano , and a net purchase of 10,000 shares made by Matthew Scott Harris .

In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 20,000 shares of Altimmune Inc (ALT) were sold and 29,300 shares were bought by its insiders, resulting in a net purchase of 9,300 shares.

Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Altimmune Inc Insider Transactions

No Available Data

Healthcare Partners Vii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Healthcare Partners Vii, L.p.. You might contact Healthcare Partners Vii, L.p. via mailing address: 44 Nassau Street, Princeton Nj 08542.

Discussions on Healthcare Partners Vii, L.p.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.